vs

Side-by-side financial comparison of Dolphin Entertainment, Inc. (DLPN) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.

Dolphin Entertainment, Inc. is the larger business by last-quarter revenue ($15.6M vs $13.8M, roughly 1.1× FENNEC PHARMACEUTICALS INC.). Dolphin Entertainment, Inc. runs the higher net margin — 6.5% vs -34.7%, a 41.3% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 27.0%). Over the past eight quarters, Dolphin Entertainment, Inc.'s revenue compounded faster (1.3% CAGR vs -26.3%).

Dolphin Entertainment, Inc. is an American entertainment marketing and production company based in Coral Gables, Florida. Founded in 1996 by Bill O'Dowd, the company produces television series and films aimed primarily at children and young adults, and owns public relations and marketing firms through acquisitions. Dolphin has also expanded into digital media, including non-fungible token (NFT) ventures and influencer marketing.

Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.

DLPN vs FENC — Head-to-Head

Bigger by revenue
DLPN
DLPN
1.1× larger
DLPN
$15.6M
$13.8M
FENC
Growing faster (revenue YoY)
FENC
FENC
+46.8% gap
FENC
73.8%
27.0%
DLPN
Higher net margin
DLPN
DLPN
41.3% more per $
DLPN
6.5%
-34.7%
FENC
Faster 2-yr revenue CAGR
DLPN
DLPN
Annualised
DLPN
1.3%
-26.3%
FENC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DLPN
DLPN
FENC
FENC
Revenue
$15.6M
$13.8M
Net Profit
$1.0M
$-4.8M
Gross Margin
96.6%
Operating Margin
9.5%
-18.5%
Net Margin
6.5%
-34.7%
Revenue YoY
27.0%
73.8%
Net Profit YoY
152.0%
-141.1%
EPS (diluted)
$0.10
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLPN
DLPN
FENC
FENC
Q4 25
$15.6M
$13.8M
Q3 25
$14.8M
$12.5M
Q2 25
$14.1M
$9.7M
Q1 25
$12.2M
$8.8M
Q4 24
$12.3M
$7.9M
Q3 24
$12.7M
$7.0M
Q2 24
$11.4M
$7.3M
Q1 24
$15.2M
$25.4M
Net Profit
DLPN
DLPN
FENC
FENC
Q4 25
$1.0M
$-4.8M
Q3 25
$-365.5K
$-638.0K
Q2 25
$-1.4M
$-3.2M
Q1 25
$-2.3M
$-1.2M
Q4 24
$-2.0M
$-2.0M
Q3 24
$-8.7M
$-5.7M
Q2 24
$-1.6M
$-5.6M
Q1 24
$-326.8K
$12.8M
Gross Margin
DLPN
DLPN
FENC
FENC
Q4 25
96.6%
Q3 25
95.6%
Q2 25
94.7%
Q1 25
97.2%
Q4 24
96.1%
Q3 24
98.0%
Q2 24
98.1%
Q1 24
84.8%
Operating Margin
DLPN
DLPN
FENC
FENC
Q4 25
9.5%
-18.5%
Q3 25
2.1%
-1.5%
Q2 25
-0.4%
-28.3%
Q1 25
-14.6%
-9.2%
Q4 24
-11.2%
-11.8%
Q3 24
-64.3%
-74.6%
Q2 24
-9.8%
-69.4%
Q1 24
1.1%
54.2%
Net Margin
DLPN
DLPN
FENC
FENC
Q4 25
6.5%
-34.7%
Q3 25
-2.5%
-5.1%
Q2 25
-10.0%
-32.7%
Q1 25
-19.1%
-13.3%
Q4 24
-15.9%
-25.0%
Q3 24
-68.5%
-82.2%
Q2 24
-14.2%
-76.5%
Q1 24
-2.1%
50.6%
EPS (diluted)
DLPN
DLPN
FENC
FENC
Q4 25
$0.10
$-0.17
Q3 25
$-0.03
$-0.02
Q2 25
$-0.13
$-0.11
Q1 25
$-0.21
$-0.04
Q4 24
$-0.21
$-0.02
Q3 24
$-0.80
$-0.21
Q2 24
$-0.17
$-0.20
Q1 24
$-0.04
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLPN
DLPN
FENC
FENC
Cash + ST InvestmentsLiquidity on hand
$8.8M
$36.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$9.7M
$35.5M
Total Assets
$58.3M
$70.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLPN
DLPN
FENC
FENC
Q4 25
$8.8M
$36.8M
Q3 25
$7.8M
$21.9M
Q2 25
$8.7M
$18.7M
Q1 25
$7.1M
$22.7M
Q4 24
$8.2M
$26.6M
Q3 24
$5.7M
$40.3M
Q2 24
$8.7M
$43.1M
Q1 24
$6.4M
$51.2M
Total Debt
DLPN
DLPN
FENC
FENC
Q4 25
Q3 25
$19.4M
Q2 25
$19.4M
Q1 25
$19.4M
Q4 24
$19.3M
Q3 24
$32.1M
Q2 24
$31.8M
Q1 24
$31.3M
Stockholders' Equity
DLPN
DLPN
FENC
FENC
Q4 25
$9.7M
$35.5M
Q3 25
$8.4M
$-4.5M
Q2 25
$7.9M
$-7.5M
Q1 25
$9.3M
$-5.9M
Q4 24
$11.6M
$-5.9M
Q3 24
$13.6M
$-5.2M
Q2 24
$20.4M
$-1.4M
Q1 24
$20.3M
$3.0M
Total Assets
DLPN
DLPN
FENC
FENC
Q4 25
$58.3M
$70.6M
Q3 25
$60.0M
$49.3M
Q2 25
$58.6M
$44.9M
Q1 25
$58.6M
$46.4M
Q4 24
$58.4M
$44.9M
Q3 24
$57.3M
$58.9M
Q2 24
$65.6M
$63.2M
Q1 24
$65.1M
$69.2M
Debt / Equity
DLPN
DLPN
FENC
FENC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
10.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLPN
DLPN
FENC
FENC
Operating Cash FlowLast quarter
$576.6K
$-6.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.57×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLPN
DLPN
FENC
FENC
Q4 25
$576.6K
$-6.0M
Q3 25
$-2.4M
$1.5M
Q2 25
$1.5M
$-3.7M
Q1 25
$-1.7M
$-4.3M
Q4 24
$850.2K
$-1.5M
Q3 24
$-1.7M
$-2.2M
Q2 24
$1.8M
$-8.4M
Q1 24
$-1.2M
$39.0M
Free Cash Flow
DLPN
DLPN
FENC
FENC
Q4 25
Q3 25
$-2.4M
Q2 25
Q1 25
$-1.7M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
DLPN
DLPN
FENC
FENC
Q4 25
Q3 25
-16.3%
Q2 25
Q1 25
-14.0%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
DLPN
DLPN
FENC
FENC
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
DLPN
DLPN
FENC
FENC
Q4 25
0.57×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
3.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons